Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2009

Open Access 01-12-2009 | Research article

Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment

Authors: Li-Chu Sun, Koung-Shing Chu, Su-Chen Cheng, Chien-Yu Lu, Chao-Hung Kuo, Jan-Sing Hsieh, Ying-Ling Shih, Shun-Jen Chang, Jaw-Yuan Wang

Published in: BMC Cancer | Issue 1/2009

Login to get access

Abstract

Background

The aim of this study was to determine influence of prognostic factors in addition to UICC staging systems, on cancer-specific and overall survival rates for patients with colorectal cancer (CRC) undergoing surgical treatment.

Methods

Between January 1996 and December 2006, a total of 1367 CRC patients who underwent surgical treatment in Kaohsiung Medical University Hospital were analyzed. We retrospectively investigated clinicopathologic features of these patients. All patients were followed up intensively, and their outcomes were investigated completely.

Results

Of 1367 CRC patients, there were seven hundred and fifty-seven males (55.4%) and 610 (44.6%) females. The median follow-up period was 60 months (range, 3–132 months). A multivariate analysis identified that low serum albumin level (P = 0.011), advanced UICC stage (P < 0.001), and high carcinoembryonic antigen (CEA) level (P < 0.001) were independent prognostic factors of cancer-specific survival. Meanwhile, a multivariate analysis showed age over 65 years (P < 0.001), advanced UICC stage (P < 0.001), and high CEA level (P < 0.001) were independent prognostic factors of overall survival. Furthermore, combination of UICC stage, serum CEA and albumin levels as predictors of cancer-specific survival showed that the poorer the prognostic factors involved, the poorer the cancer-specific survival rate. Likewise, combination of UICC stage, age and serum CEA level as predictors of overall survival showed that the poorer the prognostic factors involved, the poorer the overall survival rate. Of these prognostic factors, preoperative serum CEA level was the only significant prognostic factor for patients with stage II and III CRCs in both cancer-specific and overall survival categories.

Conclusion

Preoperative serum albumin level, CEA level and age could prominently affect postoperative outcome of CRC patients undergoing surgical treatment. In addition to conventional UICC staging system, it might be imperative to take these additional characteristics of factors into account in CRC patients prior to surgical treatment.
Appendix
Available only for authorised users
Literature
1.
International Union against Cancer: TNM classification of malignant tumors. 2002, New York: Wiley-Liss, Inc, 6
2.
Bannura G, Cumsille MA, Contreras J, Barrera A, Melo C, Soto D: Carcinoembryonic antigen (CEA) as an independent prognostic factor in colorectal carcinoma. Rev Med Chil. 2004, 132: 691-700.CrossRefPubMed
3.
Wang JY, Lu CY, Chu KS, Ma CJ, Wu DC, Tsai HL, Yu FJ, Hsieh JS: Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer. Eur Surg Res. 2007, 39: 245-250. 10.1159/000101952.CrossRefPubMed
4.
Ma CJ, Hsieh JS, Wang WM, Su YC, Huang CJ, Huang TJ, Wang JY: Multivariate analysis of prognostic determinants for colorectal cancer patients with high preoperative serum CEA levels: prognostic value of postoperative serum CEA levels. Kaohsiung J Med Sci. 2006, 22: 604-609. 10.1016/S1607-551X(09)70360-2.CrossRefPubMed
5.
Dixon MR, Haukoos JS, Udani SM, Naghi JJ, Arnell TD, Kumar RR, Stamos MJ: Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg. 2003, 138: 962-966. 10.1001/archsurg.138.9.962.CrossRefPubMed
6.
Veingerl B: Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma. Wien Klin Wochenschr. 2001, 113 (Suppl 3): 32-38.PubMed
7.
Wang WS, Lin JK, Chiou TJ, Liu JH, Fan FS, Yen CC, Lin TC, Jiang JK, Yang SH, Wang HS, Chen PM: Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience. Jpn J Clin Oncol. 2000, 30: 12-16. 10.1093/jjco/hyd003.CrossRefPubMed
8.
Heys SD, Walker LG, Deehan DJ, Eremin OE: Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb. 1998, 43: 163-168.PubMed
9.
Paul Hermanek: Prognostic factor research in oncology. J Clin Epidemiol. 1999, 52: 371-374. 10.1016/S0895-4356(98)00177-2.CrossRef
10.
Cengiz O, Kocer B, Surmeli S, Santicky MJ, Soran A: Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma. Med Sci Monit. 2006, 12: CR240-247.PubMed
11.
Lis CG, Grutsch JF, Vashi PG, Lammersfeld CA: Is serum albumin an independent predictor of survival in patients with breast cancer?. JPEN J Parenter Enteral Nutr. 2003, 27: 10-15. 10.1177/014860710302700110.CrossRefPubMed
12.
Al-Shaiba R, McMillan DC, Angerson WJ, Leen E, McArdle CS, Horgan P: The relationship between hypoalbuminemia, tumor volume and the systemic inflammatory response in patients with colorectal liver metastases. Br J Cancer. 2004, 91: 205-207.PubMedPubMedCentral
13.
McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR, McArdle CS: Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weigh loss. Nutr Cancer. 2001, 39: 210-213. 10.1207/S15327914nc392_8.CrossRefPubMed
14.
Gold P, Freedman SO: Demonstration of Tumor-Specific Antigens in Human Colonic Carcinomata by Immunological Tolerance and Absorption Techniques. J Exp Med. 1965, 121: 439-462. 10.1084/jem.121.3.439.CrossRefPubMedPubMedCentral
15.
Hammarstrom S: The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol. 1999, 9: 67-81. 10.1006/scbi.1998.0119.CrossRefPubMed
16.
Duffy MJ: Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?. Clin Chem. 2001, 47: 624-630.PubMed
17.
Carriquiry LA, Pineyro A: Should carcinoembryonic antigen be used in the management of patients with colorectal cancer?. Dis Colon Rectum. 1999, 42: 921-929. 10.1007/BF02237104.CrossRefPubMed
18.
Sener SF, Imperato JP, Chmiel J, Fremgen A, Sylvester J: The use of cancer registry data to study preoperative carcinoembryonic antigen level as an indicator of survival in colorectal cancer. CA Cancer J Clin. 1989, 39: 50-57. 10.3322/canjclin.39.1.50.CrossRefPubMed
19.
Chapman MA, Buckley D, Henson DB, Armitage NC: Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer. 1998, 78: 1346-1349.CrossRefPubMedPubMedCentral
20.
Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF: Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med. 1978, 299: 448-451.CrossRefPubMed
21.
Tsuchiya A, Ando Y, Kikuchi Y, Kanno M, Sato H, Yoshida T, Abe R: Reappraisal of preoperative carcinoembryonic antigen levels as a prognostic factor in resectable colorectal cancer. Fukushima J Med Sci. 1994, 40: 9-17.PubMed
22.
Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, Manfredi S, Dancourt V, Faivre J: Colon cancer in France: evidence for improvement in management and survival. Gut. 2002, 51: 60-64. 10.1136/gut.51.1.60.CrossRefPubMedPubMedCentral
23.
Bufalari A, Giustozzi G, Burattini MF, Servili S, Bussotti C, Lucaroni E, Ricci E, Sciannameo F: Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors. J Surg Oncol. 2006, 93: 173-180. 10.1002/jso.20300.CrossRefPubMed
24.
Schiffmann L, Ozcan S, Schwarz F, Lange J, Prall F, Klar E: Colorectal cancer in the elderly: surgical treatment and long-term survival. Int J Colorectal Dis. 2008, 23: 601-610. 10.1007/s00384-008-0457-5.CrossRefPubMed
25.
O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Ko CY: Are survival rates different for young and older patients with rectal cancer?. Dis Colon Rectum. 2004, 47: 2064-2069. 10.1007/s10350-004-0738-1.CrossRefPubMed
26.
Driver JA, Djousse L, Logroscino G, Gaziano JM, Kurth T: Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ. 2008, 337: a2467-2474. 10.1136/bmj.a2467.CrossRefPubMedPubMedCentral
27.
Marusch F, Koch A, Schmidt U, Steinert R, Ueberrueck T, Bittner R, Berg E, Engemann R, Gellert K, Arbogast R, Korner T, Kockerling F, Gastinger I, Lippert H: The impact of the risk factor "age" on the early postoperative results of surgery for colorectal carcinoma and its significance for perioperative management. World J Surg. 2005, 29: 1013-1021. 10.1007/s00268-005-7711-6. discussion 1021-1012CrossRefPubMed
28.
Marusch F, Koch A, Schmidt U, Zippel R, Gastmeier J, Geissler S, Pross M, Gastingwer I, Lippert H: Impact of age on the short-term postoperative outcome of patients undergoing surgery for colorectal carcinoma. Colorectal Dis. 2002, 17: 177-184. 10.1007/s003840100344.CrossRef
Metadata
Title
Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
Authors
Li-Chu Sun
Koung-Shing Chu
Su-Chen Cheng
Chien-Yu Lu
Chao-Hung Kuo
Jan-Sing Hsieh
Ying-Ling Shih
Shun-Jen Chang
Jaw-Yuan Wang
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2009
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-9-288

Other articles of this Issue 1/2009

BMC Cancer 1/2009 Go to the issue

Research article

Ovarian cancer survival population differences: a "high resolution study" comparing Philippine residents, and Filipino-Americans and Caucasians living in the US

Research article

The intraportal injection model: A practical animal model for hepatic metastases and tumor cell dissemination in human colon cancer

Research article

Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study

Research article

δ-ALA-D activity is a reliable marker for oxidative stress in bone marrow transplant patients

Research article

Bone sialoprotein does not interact with pro-gelatinase A (MMP-2) or mediate MMP-2 activation

Research article

Sensitive HPV detection in oropharyngeal cancers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits